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KETEPATAN SITOLOGI SEDUTAN JARUM HALUS TIROID 
DENGAN MENGGUNAKAN SISTEM BETHESDA: KAJIAN 
BERASASKAN SEBUAH HOSPITAL 
 
ABSTRAK 
Tujuan:Di Hospital Universiti Sains Malaysia, The Bethesda System of 
Reporting Thyroid Cytology (TBSRTC) tidak digunakan secara meluas oleh ahli 
patologi atau pakar bedah/doktor. Sebaliknya, sistem laporan konvensional 
telah digunakan dan hasilnya tidak diberi klasifikasi berperingkat seperti dalam 
TBSRTC. Ini adalah satu kajian retrospektif untuk mengkaji semula semua 
FNACs tiroid dengan korelasi pemeriksaan histopatologi dalam tempoh 5 tahun 
(2010-2014) berdasarkan Sistem Bethesda 2010 dan untuk mencari ketepatan 
serta sensitiviti dan spesifisiti. 
 
Kaedah:Kami telah mengenal pasti sebanyak 563 kes FNAC tiroid dilakukan 
dari Januari 2010 hingga Disember 2014 di Hospital Universiti Sains Malaysia 
(HUSM), sebuah hospital pengajaran di Kelantan, yang membentuk populasi 
kajian kami. Semua kes-kes telah dikenal pasti dari pangkalan data Sistem 
Maklumat Makmal (LIS) di Jabatan Patologi, Hospital Universiti Sains MAlaysia. 
Selepas memansuhkan kes-kes yang mempunyai kriteria pengecualian, 
sejumlah 110 kes FNAC tiroid telah dimasukkan dalam kajian ini.Kes-kes 
tersebut adalah FNAC tiroid yang mempunyai kualiti slaid yang baik dan yang 
mempunyai keputusan pemeriksaan histopatologi  (HPE). Penyiasat utama, 
pakar patologi dan sitopatologis yang mengkaji semua slaid daripada 110 kes 
akan memberi diagnosis sepakat dengan menggunakan kriteria yang telah 
 XI 
ditetapkan oleh TBSRTC. SPSS versi 20.0 digunakan untuk kemasukan data 
dan analisis. Statistik deskriptif digunakan untuk data sosio-demografi. Perisian 
Stata digunakan untuk nilai-p dengan menggunakan ujian Fisher Exact untuk 
nombor Objektif 2. Formula statistik digunakan untuk mengira 
ketepatan,spesifikasi dan sensitiviti. 
 
Keputusan:Umur pesakit adalah dari 11 hingga 80 tahun. Min umur pesakit 
termasuk dalam kajian ini adalah 44,70 +/- 14.52 (min +/- SD) tahun. Terdapat 
94 atau 85.5% wanita dan 16 atau 14.5% pesakit lelaki. Antara 110 kes yang 
telah dikaji semula menggunakan TBRSTC, 78 kes atau 70.9% telah dilaporkan 
sebagai benigna pada sitologi, 1 kes atau 0.9% dilaporkan ‘Atypia of 
Undetermined Significant’, 9 kes atau 8.2% telah dilaporkan sebagai ‘follicular 
neoplasm’, 9 kes atau 8.2% telah dilaporkan sebagai ‘suspicious of malignancy’ 
dan 13 kes atau 11.8% telah dilaporkan sebagai ‘malignant’. Korelasi sito-
histopatologi menunjukkan 29 kes atau 26.4% adalah TP, 75 kes atau 68.2% 
adalah TN, 3 kes atau 2.7% adalah FP dan 3 kes atau 2.7% adalah FN. 
Pemeriksaan histopatologi menunjukkan, 25 kes atau 22.7% adalah malignan 
dan 85 kes atau 77.3% adalah benigna. Antara pesakit wanita, 76 kes atau 
81% adalah benigna dan 18 kes atau 19% adalah histologi malignan. 
Manakala, di kalangan pesakit lelaki, 7 kes atau 44% adalah benigna dan 9 kes 
atau 56% malignan. 18 kes atau 66.7% kes malignan adalah wanita dan 9 kes 
atau 33.3% kes malignan adalah lelaki. 76 kes atau 91.6% kes benigna adalah 
wanita dan 7 kes atau 8.4% daripada kes-kes benigna adalah lelaki. 
Korelasi sito-histopatologi menunjukkan 96.2% benigna dan 3.8% 
malignan dalam Bethesda II (benign), 100% malignan dalam Bethesda III (AUS 
 XII 
/ FLUS), 55.6% benigna dan 44.4% malignan dalam Bethesda IV (neoplasma 
folikel), 33.3% benigna dan 66.7% malignan dalam Bethesda V (kecurigaan 
malignan) dan 100% malignan dalam Bethesda VI (malignan). Secara statistik, 
ketepatan keseluruhan tiroid FNAC dengan menggunakan Sistem Bethesda 
adalah 94.5%, sensitiviti adalah 90.6% dan spesifisiti adalah 96.1%. Nilai 
ramalan positif adalah 90.6% dan nilai ramalan negatif adalah 96.1%. Dengan 
melihat setiap kategori, benign (kategori II) mempunyai 96% ketepatan, AUS 
(kategori III) mempunyai ketepatan 100%, neoplasma folikel (kategori IV) 
mempunyai 100% ketepatan, kecurigaan malignan (Kategori V) mempunyai 
66% ketepatan dan malignan (kategori VI) mempunyai 100% ketepatan. 
 
Kesimpulan:Dari kajian ini, kami membuat kesimpulan bahawa FNA adalah 
kaedah yang paling tepat dan kos efektif untuk menilai nodul tiroid. Kajian ini 
juga menyimpulkan bahawa The Bethesda System of Reporting Thyroid 
Cytology, 2010 mempunyai ketepatan yang tinggi, spesifisiti dan 
sensitiviti.Sistem ini juga boleh meningkatkan ketepatan dalam kategori 
malignan (kategori VI). 
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ACCURACY OF THYROID FINE NEEDLE ASPIRATION 
CYTOLOGY BY USING BETHESDA SYSTEM: A HOSPITAL 
BASED STUDY 
 
ABSTRACT 
 
Aim: In Hospital University Science of Malaysia, The Bethesda System of 
Reporting Thyroid Cytology (TBSRTC) was not widely used by pathologist or 
surgeon/clinician. Instead, conventional reporting system was used and the 
result was not given tiered classification as in TBSRTC. This study is a 
retrospective study to review all thyroid FNACs with histopathological 
correlation in 5 years (2010 to 2014) base on Bethesda System and to look for 
the accuracy as well as sensitivity and specificity. 
 
Methods: We identified total of 563 thyroid FNACs cases performed from 
January 2010 till December 2014 in Hospital Universiti Sains Malaysia (HUSM), 
a teaching hospital in Kelantan, which form our study population. All cases were 
identified from the database of Laboratory Information System (LIS) in the 
Department Pathology, HUSM. After excluding the cases with exclusion criteria, 
total of 110 FNAC cases were included in this study. These cases were thyroid 
FNAC with good quality of slides and with histopathology examination (HPE) 
result. Primary investigator, a pathologist and a cytopathologist reviewed all 
slides from 110 cases and consensus diagnosis was given using TBSRTC. 
SPSS version 20.0 is used for data entry and analysis. Descriptive statistic is 
used for socio demographic data. Stata software is used for p-value by using 
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Fisher Exact test for objective number 2. Statistic formulas are used to calculate 
the accuracy, sensitivity and specificity. 
 
Results:The patients age were range from 11 to 80 years. The mean age of the 
patient included in this study was 44.70+/-14.52 (mean+/-SD) years. There 
were 94 or 85.5% female and 16 or 14.5% male patients. Among 110 cases 
which were reviewed using TBRSTC, 78 cases or 70.9% were reported as 
benign on cytology, 1 case or 0.9% was reported as Atypia of Undetermined 
Significant (AUS), 9 cases or 8.2% were reported as follicular neoplasm, 9 
cases or 8.2% were reported as suspicious of malignancy and 13 cases or 
11.8% were reported as malignancy. Cyto-histopathological correlation shows 
29 cases or 26.4% were true positive, 75 cases or 68.2% were true negative, 3 
cases or 2.7% were false positive and 3 cases or 2.7% were false negative. 
Histopathological examination shows, 25 cases or 22.7% were malignant and 
85 cases or 77.3% were benign. Among female patients, 76 cases or 81% were 
benign and 18 cases or 19% were malignant histologically. Whereas, among 
male patients, 7 cases or 44% were benign and 9 cases or 56% were malignant 
histologically. 18 cases or 66.7% of malignant cases were female and 9 cases 
or 33.3% of malignant cases were male. 76 cases or 91.6% of benign cases 
were female and 7 cases or 8.4% of benign cases were male. 
Cyto-histopathological correlation shows 96.2% benign and 3.8% 
malignant in Bethesda II (benign), 100% malignant in Bethesda III (Atypia of 
Undetermined Significant/Follicular Lesion of Undetermined Significant), 55.6% 
benign and 44.4% malignant in Bethesda IV (follicular neoplasm), 33.3% benign 
and 66.7% malignant in Bethesda V (suspicious malignancy) and 100% 
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malignant in Bethesda VI (malignant). Statistically, the overall accuracy of 
thyroid FNAC by using Bethesda System is 94.5%, the sensitivity is 90.6% and 
the specificity is 96.1%. The positive predictive value is 90.6% and the negative 
predictive value is 96.1%. By looking at each categories, benign (category II) 
had 96% accuracy, AUS (category III) had 100% accuracy, follicular neoplasm 
(category IV) had 100% accuracy, suspicious of malignancy (category V) had 
66% accuracy and malignancy (category VI) had 100% accuracy. 
 
Conclusion: From this study, we conclude that FNA is the most accurate and 
cost effective method for evaluating thyroid nodule. This study also concludes 
that The Bethesda System of Reporting Thyroid Cytology have high accuracy, 
sensitivity and specificity. This system also can increase the accuracy in 
malignant category.  
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CHAPTER 1 
INTRODUCTION 
 
 Over the past decades, fine needle aspiration (FNA) has become an 
essential step in the evaluation of a thyroid nodule. The clinical application of 
FNA as an initial diagnostic tool for thyroid nodules is widespread because 
thyroid nodules are quite common. Within the general population, palpable 
thyroid nodules are present in 4% to 7% of adults, and sub-clinical (non-
palpable) nodules are present in up to 70% of individuals. Of these thyroid 
nodules, 90% to 95% are benign, and include a wide variety of lesions such as 
adenomatous nodules, simple thyroid cysts, colloid nodules, follicular 
adenomas, and inflammatory and developmental conditions, among others 
(Clark and Faquin, 2010).  
 The extremely large number of benign thyroid nodules and the small 
number of admixed malignant ones creates a clinical dilemma on how to 
manage these patients with a detectable thyroid lesion that is most likely 
benign. FNA has emerged as the most effective method for dealing with this 
problem. As a screening test for thyroid carcinoma, FNA assists in guiding the 
clinical management of patients by helping to select those individuals who are 
more likely to have a malignancy and need surgical intervention from the larger 
group of patients with benign nodules that can be managed without surgery.  
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 Fine needle aspiration is now widely accepted by endocrinologists and 
thyroid surgeons as a safe, cost-effective, and accurate for evaluating a thyroid 
nodule. Wide- spread use of FNA has reduced the number of patients requiring 
thyroid surgery by more than 50%, it has increased the yield of malignancies at 
thyroidectomy by two to three times, and it has decreased the overall cost of 
managing a thyroid nodule by more than 25% (Clark and Faquin, 2010).  
 The Bethesda System of Reporting Thyroid Cytopathology (TBSRTC) 
was established during the National Cancer Institute Thyroid FNA State of 
Science Conference hosted by National Cancer Institute in October 2007. The 
conference  which was attended by 154 participants, including pathologists, 
endocrinologists, surgeons, and radiologists, gave the committees an in-depth 
opportunity to present their conclusions and debate controversial areas (Cibas 
and Ali, 2009a).  
 The conference is to aim a uniform reporting system for thyroid FNA that 
will facilitate effective communication among health care providers; facilitate 
cytologic-histologic correlation for thyroid diseases; facilitate research into the 
epidemiology, molecular biology, pathology, and diagnosis of thyroid diseases, 
particularly neoplasia; and allow easy and reliable sharing of data from different 
laboratories for national and international collaborative studies  
 Many studies favor a tiered system for classifying thyroid FNA; this 
ranges from 5 to 6 diagnostic category schemes (Bongiovanni et. al., 2012). For 
clarity of communication, the Bethesda System for Reporting Thyroid 
Cytopathology recommends that each report begin with a general diagnostic 
category. The 6 general diagnostic categories are: category I for non-diagnostic 
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or unsatisfactory; category II for benign; category III for atypia of undetermined 
significant; category IV for follicular neoplasm; category V for suspicious for 
malignancy and category VI for malignancy. Each category has an implied 
cancer risk, which ranges from 0% to 3% for the “Benign” category to almost 
100% for the “Malignant” category. As a function of these risk associations, 
each category is linked to evidence-based clinical management guidelines 
(Cibas and Ali, 2009). 
 In Hospital Universiti Sains Malaysia, TBSRTC was not widely used by 
pathologist or surgeon/clinician. Instead, conventional reporting system was 
used and the result was not given tiered classification as in TBSRTC. The 
reason TBSRTC was not widely used could be multifactorial.  One of the factor 
might be due to lack of communication between pathologist, clinician and 
radiologist. This study is a retrospective study to review all thyroid FNACs with 
histopathological examination correlation in 5 years (2010 to 2014) base on 
Bethesda System and to look for the accuracy as well as sensitivity and 
specificity. 
 Although the study was done in many other institution and countries, this 
study which is specific to Bethesda system was never been done in Malaysia. 
Thus, this study might be helpful for the pathologist and surgeon or clinician in 
Malaysia, particularly in Hospital Universiti Sains Malaysia. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 ANATOMY OF THE THYROID GLAND 
It is essential for all cytopathologists and histopathologists to know the 
anatomy of the thyroid glands. This includes the surrounding structures nearby 
the thyroid gland, arteries and veins supplying the thyroid gland and the 
lymphatic drainage of each thyroid lobe.  
The normal adult thyroid has a shape like a butterfly, with two bulky 
lateral lobes connected by a thin isthmus. Each lateral lobe is 2 to 2.5 cm wide, 
5 to 6 cm long, and 2 cm deep. Their upper and lower extremities are referred 
to as upper and lower thyroid poles, respectively. One lobe may be larger than 
the other, and the isthmus may be exceptionally wide. The pyramidal lobe, a 
remnant of the thyroglossal duct, is found in about 40% of thyroids; it appears 
as a narrow projection of thyroid tissue that extends upward from the isthmus to 
lie on the surface of the thyroid cartilage. (Mills et al,. 2007) 
The thyroid gland is located at the anterior of the neck, where it is 
attached to the trachea by loose connective tissue. The two lateral lobes 
surround the ventral and lateral aspects of the larynx and trachea, reaching the 
lower halves of the thyroid cartilage and covering the second, third, and fourth 
tracheal rings (Figure 2.1). 
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The normal weight of the adult thyroid is 15 to 25 g. However, there are 
significant individual variations, most of them related to gender, age, corporal 
weight, hormonal status, functional status of the gland, and iodine intake. In 
women, the thyroid volume is known to increase during the secretory phase of 
the menstrual cycle (Mills et al, 2007). 
. 
 
Figure 2.1: Anatomy of the thyroid gland and its surrounding structures 
Adapted from Atlas of Human Anatomy 
 
 
Grossly, the color of the normal thyroid is beefy and brown. Occasionally, 
elderly individuals have accumulation of a melanin-like pigment in the follicular 
cells that give coal black stain, which can be seen on gross examination. The 
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terms melanosis thyroid and black thyroid are used to refer to this phenomenon. 
These changes are qualitatively identical to those seen in more florid form in 
thyroids of patients on chronic minocycline. Nodularity of thyroid parenchyma is 
identified grossly in about 10% of the glands of endocrinologically normal 
individuals  (Mills et al, 2007). 
The blood supply of the thyroid gland derives primarily from the 
inferiorthyroid artery, which originates from the thyrocervical trunk of the 
subclavian artery, and the superior thyroid artery, which arises from the external 
carotid. A thyroidea ima artery also may be present, which varies widely in size 
from a small vessel to one the size of the inferior thyroid artery. The superior 
and medial thyroid veins and the inferior vein drain (via a venous plexus in the 
thyroid capsule) into the internal jugular and the brachiocephalic vein, 
respectively (Mills et al,. 2007).  
The lymphatic network permeates the thyroid gland, encircling the 
follicles and it empties into subcapsular channels, which in turn give rise to 
collecting trunks within the thyroid capsule. The lymph vessels draining the 
superior portion of the thyroid lobes and isthmus collect into the internal jugular 
lymph nodes, whereas those draining the inferior portion of the gland collect 
into the pre- and paratracheal and prelaryngeal lymph nodes. The pretracheal 
lymph node situated close to the isthmus is also known as the Delphian node. 
Other lymph node stations are the recurrent laryngeal nerve chain and the 
retropharyngeal and retroesophageal groups. The anterosuperior mediastinal 
nodes are secondary to the recurrent laryngeal nerve chain and pretracheal 
groups; however, injection studies have shown that dye injected into the thyroid 
isthmus can drain directly into the mediastinal nodes (Mills et al,. 2007). 
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 Correlations exist between the site of a thyroid tumor within a given lobe 
and the location of the initial lymph node metastasis. However, the degree of 
anastomosing between these various nodal groups is such that any of them can 
be found to be the site of disease regardless of the precise location of the 
primary tumor (Mills et al,. 2007). 
 
2.2 PREVALENCE OF THYROID LESION 
   
2.2.1 Prevalence in the world 
Thyroid nodules are common and are commonly benign. The reported 
prevalence of nodular thyroid disease depends on the population studied and 
the methods used to detect nodules. The incidence increases with age, and is 
increased in women, in people with iodine deficiency, and after radiation 
exposure. Numerous studies suggest a prevalence of 2–6% with palpation, 19–
35% with ultrasound, and 8–65%in autopsy data (Dean and Gharib, 2008). In 
US, there are between 5% to 7% of adults have a clinically detectable nodule in 
the thyroid and 30% to 50% of adults have one or more nodules in the thyroid 
when the gland is examined by ultrasound. (McDougall, 2007) 
However, in one study the prevalence of thyroid nodules in a healthy 
population is high. In the German Papillon study, nationwide ultrasound 
screening of more than 90 000 people using 7.5 MHz scanners revealed the 
presence of thyroid nodules in 33% of the normal population and a study using 
13MHz ultrasound examination showed 68% of thyroid lesion were detected in 
635 candidates (Guth et al., 2009). In another study in China, the prevalence of 
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thyroid nodule among men and women was 24.1% and 34.7%, respectively (Xu 
et al., 2014). The majority of clinically diagnosed thyroid nodules are non-
neoplastic; only 5%–30% are malignant and require surgical intervention (Gupta 
et al., 2010).  
 
 
2.2.2 Prevalence in Malaysia and Kelantan 
In West Malaysia, the northeastern region including Kelantan has a high 
incidence of multinodular goiter, with incidence of 31.4% in coastal/ lowland 
areas to 45.0% in the inland areas (Mafauzy et al., 1995). Thyroid cancer is the 
fourth most common cancer among female in Kelantan comprising 7.2% from 
all cancer patients. This is much higher compared to 3% incidence of thyroid 
cancer, which is 9th most common cancer among female in Malaysia (Zainal 
and Nor Saleha, 2011).  
The number of thyroid samples received in pathology laboratory in Hospital 
Universiti Sains Malaysia were increasing in number which were quadruple in 
10 years (Othman et al., 2009) (Figure 2.2). This increment is similar to the 
thyroid cancer cases worldwide, which is inversely proportionate (Figure 2.3). 
Eleven years of study in Pathology Laboratory Hospital Universiti Sains 
Malaysia showed that 76.5% of thyroid nodules were benign and 23.5% were 
malignant. 
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Figure 2.2: The number of thyroid samples received in Pathology Laboratory, 
Hospital University Sains Malaysia 1994-2004. 
Adapted from (Othman et al., 2009) 
 
 
Figure 2.3: Number of thyroid cancer from 1976 to 2003 
Adapted from (Mcdougall, 2007) 
 
 
Nor Hayati Othman et al
Asian Pacific Journal of Cancer Prevention, Vol 10, 200988
The hospital-based incidence for common thyroid diseases
was calculated based on the number of thyroid disease
confirmed histopathologically over the number of patients
attending the outpatients specialists clinics at HUSM
during the same period multiply by 100,000.  This figure
was divided by eleven (the duration of the study period)
to give a yearly incidence.
Results
A total of 1486 thyroid specimens were received by
Department of Pathology HUSM from 1994 to 2004.
Majority 1167/1486 (78.5%) had prior FNA before
surgical removal.  During the same period, a total of
20,381 cytological and 37,926 histological samples were
seen in the same laboratory, making thyroid specimens
2.5% of the total samples examined. Four hundred and
ninety seven (497) patients had both cytological
assessment followed by histological confirmation. The
number of patients attending the specialist clinics to
HUSM over the 11-year period was 294,328 patients.
The number of thyroid samples received each year is
depicted in Figure 1. The age of the patients ranged from
12 to 85 years. Sixty nine records (4.6%) did not state the
age of the patients. The mean age was 40.9 years (SD14.6)
and the median age was 40.0 years. The female to male
ratio was 6:1.  The duration of goitre ranged from one to
15 years.
Multi-nodular goitre, also termed nodular hyperplasia,
was the most common diagnosis made by cytology; 852
(73.0%) and by histology; 322(64.8%).  Neoplastic
diagnoses were made in 166(14.1%) cases by FNA and
147(28.1%) by HPE. All neoplastic cases diagnosed by
cytology had histology confirmation. The various
diagnoses made from aspiration cytology is shown in
Figure 2.
From the 147 cases diagnosed to be neoplastic by HPE,
111 (75.5%) were malignant. The peak age of patients
with malignancy was from 30-49 years old. Majority of
the cancer was papillary carcinoma (76.6%). The hospital-
based incidence of papillary carcinoma was 2.6 per
100,000 admitted patients and follicular carcinoma was
0.6 per 100,000 (Table 1). The female to male ratio was
5.2:1. HPE showed 66/111 (59.5 %) of the cancers arose
from pre-existing nodular hyperplasia. All except two were
papillary carcinoma. From 1994 to 2004 pathology
laboratory HUSM made diagnoses of cancer in 2251 cases
(Figure 3). The average percentage of HPE confirmed
thyroid cancers seen was 4.9% of total cancers. The
percentage ranged from 1% to 7.5%.  The annual hospital-
based incidence of thyroid diseases seen in HUSM over
the 11-year period is as shown in Table 1.
Discussion
Reported studies on thyroid cancers in Malaysia are
few. The early hospital-based reports of Malaysian thyroid
cancer incidence were reported by Marsden in 1958 and
Table 1. The Hospital-based Incidences of Various
Thyroid Diseases per 100,000 Admitted Patients seen
in HUSM; 1994 to 2004
Multinodular goitre/colloid cysts 9.9
Graves’s Diseases 0.5
Thyroiditis 0.3
Follicular lesion 1.1
Thyroid Malignancies  n=111 3.5
Papillary carcinoma -76.6% 2.6
Follicular carcinoma -18.9% 0.6
Hurtle cell carcinoma -1.8% 0.1
Medullary carcinoma - 0.9% <0.1
Anaplastic carcinoma-2.7% <0.1
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Figure 1. The Number of Thyroid Samples Received
in the Pathology Laboratory, HUSM 1994 – 2004
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Figure 2. The Diagnoses Made By Fine Needle
Aspiration Cytology for Thyroid Cases Seen in HUSM;
1994 – 2004
Figure 3. The Frequency of Cancer of Thyroid
Compared to All Malignant Cases Diagnosed In
Pathology Department, HUSM 1994 – 2004
2 Thyroid Cancer in Clinical Practice
cancer but the genders are more equally represented with about 850 women 
and 650 men expected to die annually (43,000 die of road traffi c accidents and 
30,000 from gunshots in US annually!). Less than 0.5% of all cancer deaths are 
from carcinomas of the thyroid. Because the large majority of patients who 
are diagnosed with thyroid cancer have an excellent prognosis, there are 
several hundred thousand people in the US who are living with a diagnosis of 
thyroid cancer.
There are substantial differences in the prevalence of thyroid cancer among 
ethnic groups. In women, the lowest incidence is 3.3 cancers per 100,000 in 
African Americans. By comparison, women from Hawaii, Vietnam, and the 
Philippines represent 9.1, 10.5, and 14.6 cases per 100,000.3 White and Hispanic 
women have similar incidences of 6.5 and 6.2 cancers per 100,000. When age 
is also considered, Filipino women between 55 and 69 years have an incidence 
of 32.5 cancers per 100,000. Filipino men also have a higher incidence of 
thyroid cancer with 4.1 per 100,000 compared with 1.4 per 100,000 for African 
Americans. A multiethnic study in the San Francisco Bay area tried to answer 
whether there were environmental differences, but no compelling factor was 
identifi ed.
The 5-year survival for white Americans over time has been 92% (1974–
1976), 94% (1980–1982), and 95% (1989–1995); in contrast, the outcomes for 
African Americans were 88%, 94%, and 89%.
The incidence in the United Kingdom (UK) (1000 new cases annually) is 
proportionately about one fi fth of that of the US based on the respective popu-
lations. There are 2.3 thyroid cancers per 100,000 women and 0.9 per 100,000 
men. Two hundred fi fty (25%) die annually in the UK (25%) and the 5-year 
survival for women and men is 75% and 64%.4 The lower incidence and higher 
mortality in the UK might be attributable to delayed diagnosis.
0
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Figure 1.1. The graph shows increases in cases of thyroid cancer between 1976 and 2003 in 
the US. The increases in mortality are less marked. (Adapted from McDougall IR. Management 
of Thyroid Cancer and Related Nodular Disease. London: Springer-Verlag; 2006:2.)
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2.3 Fine needle aspiration cytology 
2.3.1 Introduction 
FNAC of the thyroid gland is now a well-established, first line diagnostic 
test for the evaluation of diffuse thyroid lesions as well as of thyroid nodules 
with the main purpose of screening thyroid lesions and thereby, reducing 
unnecessary surgery and avoiding possible injury of the recurrent laryngeal 
nerve, hypoparathyroidism, and thyroid hormone dependence in patients with 
benign thyroid nodules. However, the distinction of these benign lesions from 
malignant nodules cannot be based reliably on the clinical presentation alone. 
Different imaging techniques are now used for diagnosis of thyroid 
nodules like radionucleotide scanning or high-resolution ultrasonography. 
However, FNAC is still regarded as the single most accurate and cost-effective 
procedure, particularly if ultrasound is used as a guide for better sample 
collection, especially for cystic lesions. 
Published data suggest that FNA has an overall accuracy rate around 
95% in the detection of thyroid malignancy. Nevertheless, like any other test, 
FNAC has its limitations and diagnostic pitfalls. These limitations include false 
negative and false positive results. Some of FNA results are not obviously 
benign or malignant and fall into the indeterminate (AUS/FLUS) or suspicious 
group.  
The reported pitfalls are those among others, related to specimen 
adequacy, sampling techniques, the skill of the physician performing the 
aspiration, the experience of the pathologist interpreting the aspirate and the 
overlapping cytological features between some benign and malignant thyroid 
lesions. 
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2.3.2 Indication for FNA thyroid 
Before a decision is made to perform an FNA, a complete history should 
be obtained; a physical examination directed to the thyroid gland and cervical 
lymph nodes should be performed; and a serum thyrotropin level (TSH) and 
thyroid ultrasound (US) should be obtained (Baloch and LiVolsi, 2006) (Baloch 
et al., 2008).  
Significant history or physical examination findings that increase the 
likelihood of malignancy include a family history of thyroid cancer, prior head 
and neck or total body irradiation, rapid growth of the nodule, a very firm or hard 
nodule, hoarseness or vocal cord paralysis, ipsilateral cervical 
lymphadenopathy, and fixation of the nodule to surrounding tissues. 
Patients with a normal or elevated serum TSH level should proceed to a 
thyroid US to determine if an FNA needs to be performed, those with a 
depressed serum TSH should have a radionuclide thyroid scan, the results of 
which should be correlated with the sonographic findings (Kendall-Taylor, 2003) 
(Hussein, 2012). Functioning thyroid nodules in the absence of significant 
clinical findings do not require an FNA because the incidence of malignancy is 
exceedingly low. A nodule that appears either iso- or hypo-functioning on 
radionuclide scan should be considered for FNA based on the US findings 
(Hussein, 2012).  
A palpation-guided FNA can be considered in the following scenarios: 
1. A thyroid nodule > 1 cm in diameter has been confirmed via US 
examination of the thyroid. The sonographic examination is important 
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because physical examination can be imprecise in determining nodule 
size and its origin from the thyroid rather than adjacent tissues. 
2. The thyroid nodule is discrete and readily identified on physical 
examination.  
3. The nodule is primarily solid (<25% cystic) on US examination. 
4. The patient has no other head or neck illnesses or prior head or neck 
surgery that may affect the thyroid anatomy. 
5. A prior non-diagnostic biopsy of the nodule has not occurred. In such 
cases, an US-guided FNA should be performed. 
6. Obtaining US guidance for FNA is logistically difficult or not readily 
available. 
 
According to 2015 American Thyroid Association (ATA) Management 
Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid 
Cancer (Haugen et al., 2016), diagnostic thyroid/neck US should be performed 
in all patients with a suspected thyroid nodule, nodular goitre, or radiographic 
abnormality suggesting a thyroid nodule incidentally detected on another 
imaging study (e.g., computed tomography (CT) or magnetic resonance 
imaging (MRI) or thyroidal uptake on 18FDG-PET scan) (Figure 2.4). Not all 
patient with thyroid nodule are indicated for FNA. The clinician should refer the 
patient to radiologist first to evaluate the thyroid nodule.  The ultrasound 
patterns will guide the clinician for further management. Below is an algorithm 
for evaluation and management of patients with thyroid nodules (Figure 2.4) 
and table of thyroid nodule sonographic patterns (Table 2.1): 
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Figure 2.4: Guideline for management of thyroid lesion 
 
Adapted from American Thyroid Association guideline 2016 
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Table 2.1: Ultrasound patterns for thyroid lesion and FNA guidance 
 
Adapted from American Thyroid Association guideline 2016 
 
 
 
Meanwhile, The British Thyroid Association (BTA) has recently 
produced an US classification (U1–U5) of thyroid nodules to facilitate the 
decision-making process regarding the need to perform fine-needle 
aspiration cytology (FNAC) for suspicious cases (Figure 2.5 to Figure 
2.10). Almost similar to the breast classification (BIRADS), this 
classification of sonographic findings can help determine whether 
aspiration is necessary (Xie et al., 2016). Similar to the American Thyroid 
Association, benign (U2) thyroid lesion is not indicated for FNAC. 
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Below is pictorial review taken from the similar literature: 
 
BTA U-
classification 
Thyroid Ultrasound and description FNAC 
U-1-Normal 
 
a. Axial view of right thyroid lobe (Th). Isthmus (Is) is anterior to 
the trachea (Tra). The carotid artery (C) is round and hypo-
echogenic located laterally to the thyroid. Internal jugular vein (J) 
is lateral to the carotid artery. Strap muscle (SM) and 
sternocleidomastoid muscle (SCM) wrap around the anterior 
aspect of the thyroid.  
b. Longitudinal view of the right thyroid lobe.  
Not required 
 
Figure 2.5: Ultrasound classification U1 (BTA) 
Adapted from (Xie et.al, 2016). 
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BTA U-
classification 
Thyroid Ultrasound and description FNAC 
U2(a)- Benign: 
Halo, iso-
echoic, mild 
hyper-echoic 
 
 
a. A benign nodule 
Not required 
U2(b)- Benign: 
cystic change 
+/- ring down 
sign, (colloid) 
 
b. A benign cystic nodule with multiple colloid, which 
are seen as multiple hyperechoic spots with 
comet-tail. 
Not required 
U2(c)- Benign: 
Microcystic, 
spongiform 
 
c. A benign nodule with hypo-echoic cystic spaces 
resulting in spongiform appearance. 
Not required 
 
Figure 2.6: Ultrasound classification U2 
Adapted from (Xie et.al.,2016) 
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U2(d&e)- 
Benign: egg 
shell 
calcification 
 
d. A benign nodule with egg shell calcification. 
 
e. A benign nodule with egg shell calcification. 
Not required 
U2(f)- 
Benign: 
Peripheral 
vascularity 
 
f. A benign nodule with peripheral vascularity. 
Not required 
 
Figure 2.7: Ultrasound classification U2 
Adapted from (Xie et.al,2016) 
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BTA U- 
classification 
Thyroid ultrasound & description FNAC 
U3 (a) – 
Indeterminate: 
Homogenous, 
hyper-echoic 
(markedly), 
solid, halo 
(follicular 
lesion)  
  
a. A markedly hyper-echogenic nodule is considered indeterminate 
regarding its malignant risk.  
Required 
U3 (b) – 
Indeterminate: 
?Hypo-
echoic, 
equivocal 
echogenic 
foci, cystic 
change  
 
 
b. A nodule containing an echogenic focus that appears to be cystic is 
indeterminate.  
Required 
U3 (c) – 
Indeterminate: 
Mixed 
vascularity  
 
 
c. Doppler assessment of a nodule showing mixed vascularity, which 
consists of both peripheral and intra-nodular vasculature.  
Required 
 
Figure 2.8: Ultrasound classification U3 
Adapted from Xie et.al 
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BTA U- 
classification 
Thyroid ultrasound & description FNAC 
U4 (a) – 
Suspicious: 
Solid, hypo-
echoic (cf 
thyroid)  
 
 
a. A suspicious hypo-echoic nodule with signal lower than the 
surrounding thyroid tissue but higher than the strap muscle above.  
Required 
U4 (b) – 
Suspicious: 
Solid, very 
hypo-echoic 
(cf strap 
muscle)  
 
 
b. A suspicious hypo-echoic nodule with signal lower than both thyroid 
tissue and strap muscle.  
Required 
U4 (c) – 
Suspicious: 
Disrupted 
peripheral 
calcification, 
hypo- echoic  
 
 
c. A suspicious hypo-echoic nodule with interrupted eggshell 
calcification around the edges.  
Required 
 
Figure 2.9: Ultrasound classification U4 
Adapted from (Xie et.al.,2016) 
 
 
	 20	
 
BTA U- 
classification 
Thyroid ultrasound & description FNAC 
U5 (a) – 
Malignant: 
Solid, hypo-
echoic, 
lobulated / 
irregular 
outline, 
micro-
calcification 
(?Papillary 
carcinoma)  
 
 
a. This hypo-echoic nodule has small hyper-echoic foci of calcification and 
an irregular lobulated contour. FNAC confirmed papillary thyroid cancer.  
Required 
U5 (b) – 
Malignant: 
Solid, hypo-
echoic, 
lobulated / 
irregular 
outline, 
globular 
calcification 
(?Medullary 
carcinoma)  
 
 
b. This hypo-echoic nodule has a single coarse globular calcification and 
an irregular contour. FNAC confirmed medullary thyroid cancer.  
Required 
U5 (c) – 
Malignant: 
Intra- 
nodular 
vascularity  
 
 
c. Thyroid nodule with intra-nodular vascularity. Later confirmed to be 
papillary thyroid cancer.  
Required 
 
Figure 2.10: Ultrasound classification U5 
Adapted from (Xie et.al,2016) 
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Published data suggest that FNA has an overall sensitivity rate around 62% 
to 94%, specificity rate around 58% to 99% and accuracy rate around 64% to 
95% in the detection of thyroid malignancy (Tables 2.2) and Pitman et al. 
(2008), in her synopsis stated that the median sensitivity of FNAC of thyroid is 
96%. One study using 170 samples show 98.5% specificity (Kessler et. 
al.,2005). 
Table 2.2: Comparison of sensitivity, specificity, accuracy, negative predictive 
value and positive predictive value 
Adapted from (Gupta et.al,2010) 
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2.3.3 The Bethesda System of Reporting Thyroid Pathology 
 
The Bethesda System of reporting thyroid pathology is a uniform 
terminology for reporting thyroid FNA results. A uniform reporting system for 
thyroid FNA will facilitate effective communication among cytopathologists, 
endocrinologists, surgeons, radiologists, and other health care providers; 
facilitate cytologic-histologic correlation for thyroid diseases; facilitate research 
into the epidemiology, molecular biology, pathology, and diagnosis of thyroid 
diseases, particularly neoplasia; and allow easy and reliable sharing of data 
from different laboratories for national and international collaborative studies 
(Cibas and Ali, 2009a) 
Beside the primary purpose of the terminology that is clarity of 
communication, the interpretation should provide clinically relevant information 
that will assist referring physicians in the management of patients. The terms for 
reporting results should have an implied risk of malignancy on which 
recommendations for patient management (eg, annual follow-up, repeated 
FNA, surgical lobectomy, near total thyroidectomy) can be given (Cibas and Ali, 
2009). 
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Table 2.3: Recommended diagnostic categories in TBSRTC 
Adapted from (Cibas and Ali, 2009) 
 
Table 2.4: Implied risk of malignancy and recommended management 
Adapted from (Cibas and Ali, 2009) 
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A study reported 100% of accuracy in thyroid FNAC study title ‘A histological 
assessment of the Bethesda system for reporting thyroid cytopathology (2010) 
abnormal categories: a series of 219 consecutive cases’ (Tepeoǧlu et al., 
2014). Another study reported sensitivity of 92.8%, a specificity of 94.2%, and a 
total accuracy of 93.6% in one study (Sinna and Ezzat, 2012). In one latest 
study showed 100% sensitivity using Bethesda system compared to 77% 
sensitivity using conventional system (M. Mamatha et al., 2015). Another study 
using 6362 cases showed 97% sensitivity, 50.7% specificity and 68.8% 
accuracy using TBSRTC (Bongiovanni et. al., 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
